Skip to content

Clinical trials

Phase 3 Spasm trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spasm Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20091
20101
20112
20151
20161
20172
20181
20191
20201
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire3
Rhodes Pharmaceuticals, L.P.2
Addrenex Pharmaceuticals, Inc.1
Damascus University1
Eisai Inc.1
GlaxoSmithKline1
Hartford Hospital1
Instituto de Cardiologia de Santa Catarina1
Laboratorios Silanes S.A. de C.V.1
Neurana Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spasm16
Attention Deficit Disorder with Hyperactivity10
Back Pain4
Acute Pain1
Aneurysm1
Anxiety Disorders1
Neck Pain1
Neurodevelopmental Disorders1
Oppositional Defiant Disorder1
Pain1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.